Comparison

PEAQX European Partner

Item no. TMO-T4171-25mg
Manufacturer TargetMol
CASRN 459836-30-7
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Citations 1.Auberson YP, et al. 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1099-102.
Smiles C(N[C@@H](C)C1=CC=C(Br)C=C1)(P(=O)(O)O)C2=C3C(=CC=C2)NC(=O)C(=O)N3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias NVP-AAM077
Shipping Condition Cool pack
Available
Manufacturer - Targets
NMDAR|||iGluR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
454.21
Description
PEAQX (NVP-AAM077)(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).
Pathways
Neuroscience|||Membrane transporter/Ion channel

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close